From Medscape Oncology

Coverage from the

Gastrointestinal Cancers Symposium (GICS) 2021

January 15 - 17, 2021; Virtual/Online

January 15 - 17, 2021 Virtual/Online

Potential New Standard of Care for Biliary Tract Cancer Interim data from a large phase 3 trial show that adding durvalumab to chemotherapy significantly improved overall survival vs chemotherapy alone.
Medscape Medical News, January 24, 2022
Pembro+Chemo as First-Line Standard of Care for Esophageal Cancer An additional 12 months of follow-up confirmed the benefits of the combination therapy as a first-line treatment for advanced or metastatic esophageal cancer.
Medscape Medical News, January 21, 2022
GICS 2021 Novel Blood Test Detects Precancerous Colorectal Adenomas A novel multiomics blood test was shown to detect advanced colorectal adenomas at comparable or better rates than currently available stool tests.
Medscape Medical News, January 21, 2021

Conference News

GICS 2021 Lasting Benefit With Nivo Plus Ipi in Advanced Liver Cancer
Medscape Medical News, February 1, 2021
GICS 2021 TACTICS: TACE Plus Sorafenib Improves PFS in Unresectable HCC
Medscape Medical News, February 1, 2021
GICS 2021 Higher Intensity Therapy and Surgical Risk in Esophageal Cancer
Medscape Medical News, January 29, 2021
GICS 2021 Jury's Still Out on Trifluridine/Tipiracil Plus Bev in mCRC
Medscape Medical News, January 29, 2021
GICS 2021 High Cost of Pancreatic Enzymes a Barrier for Patients With Cancer
Medscape Medical News, January 26, 2021
GICS 2021 Triplet Shows 'Promising' Activity in Unresectable/Metastatic CRC
Medscape Medical News, January 25, 2021

GICS 2021 Novel Blood Test Detects Precancerous Colorectal Adenomas
Medscape Medical News, January 21, 2021
GICS 2021 New Standard for Borderline Resectable Pancreatic Cancer
Medscape Medical News, January 20, 2021
GICS 2021 Bemarituzumab FIGHTs Gastric/GEJ Cancers, Improving Survival
Medscape Medical News, January 19, 2021
GICS 2021 Better Survival With S-1/Docetaxel in Stage III Gastric Cancer
Medscape Medical News, January 18, 2021
GICS 2021 Gut Microbiome Predicts Nivolumab Efficacy in Gastric Cancer?
Medscape Medical News, January 18, 2021

Medscape Oncology© WebMD, LLC

Any views expressed above are the author's own and do not necessarily reflect the views of WebMD or Medscape.

Expert Commentary

Highlights From ASCO GI: Data That Will 'Advance Care'
Mark A. Lewis, MD

Popular News from GICS 2020

Should Routine Colon Cancer Screening Start at 45, Not 50? The increase in colorectal cancer among younger adults has led to debate about lowering the age at which to begin screening.
Medscape Medical News, Feb 18, 2020
Should Routine Colon Cancer Screening Start at 45, Not 50? The increase in colorectal cancer among younger adults has led to debate about lowering the age at which to begin screening.
Medscape Medical News, xx-Date-Here-xx
No Benefit With Boosted Radiation Dose in Esophageal Cancer Escalating the radiation dose does not improve outcomes in patients receiving definitive chemoradiation.
Medscape Medical News, Jan 24, 2020

Previous Coverage